Loading...
Gatifloxacin Pharmacokinetics/Pharmacodynamics–based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis
BACKGROUND: Gatifloxacin is used for the treatment of multidrug-resistant tuberculosis (MDR-TB). The optimal dose is unknown. METHODS: We performed a 28-day gatifloxacin hollow-fiber system model of tuberculosis (HFS-TB) study in order to identify the target exposures associated with optimal kill ra...
Na minha lista:
| Udgivet i: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6904296/ https://ncbi.nlm.nih.gov/pubmed/30496459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy618 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|